These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan). Martin GR, Robertson AD, MacLennan SJ, Prentice DJ, Barrett VJ, Buckingham J, Honey AC, Giles H, Moncada S. Br J Pharmacol; 1997 May; 121(2):157-64. PubMed ID: 9154322 [Abstract] [Full Text] [Related]
4. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat. Hoskin KL, Goadsby PJ. Exp Neurol; 1998 Mar; 150(1):45-51. PubMed ID: 9514827 [Abstract] [Full Text] [Related]
11. Effects of serotonergic 5-HT1A and 5-HT1B ligands on ventral pallidal neuronal activity. Heidenreich BA, Napier TC. Neuroreport; 2000 Sep 11; 11(13):2849-53. PubMed ID: 11006953 [Abstract] [Full Text] [Related]
12. 5-HT(1A) and 5-HT(1B/1D) receptors are involved in the modulation of the trigeminovascular system of the cat: a microiontophoretic study. Boers PM, Donaldson C, Zagami AS, Lambert GA. Neuropharmacology; 2000 Jul 24; 39(10):1833-47. PubMed ID: 10884564 [Abstract] [Full Text] [Related]